Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734758 | SCV000862926 | uncertain significance | not provided | 2018-08-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000807737 | SCV000947806 | uncertain significance | Duchenne muscular dystrophy | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 2485 of the DMD protein (p.Trp2485Cys). This variant is present in population databases (rs765207227, gnomAD 0.004%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with DMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 598379). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000734758 | SCV000987677 | uncertain significance | not provided | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV000734758 | SCV003829495 | uncertain significance | not provided | 2021-06-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001825485 | SCV002087762 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-07-04 | no assertion criteria provided | clinical testing |